Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Clinical trial NCT02098473 · COMPLETED

Trial details

NCT number: NCT02098473
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2014-08-31
Primary completion: 2016-02-17
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.